FY2025 EPS Estimate for Colgate-Palmolive Lowered by Analyst

Colgate-Palmolive Company (NYSE:CL) – Investment analysts at Zacks Research reduced their FY2025 earnings per share estimates for Colgate-Palmolive in a report released on Friday, November 14th. Zacks Research analyst Team now anticipates that the company will earn $3.66 per share for the year, down from their prior estimate of $3.68. The consensus estimate for Colgate-Palmolive’s current full-year earnings is $3.75 per share. Zacks Research also issued estimates for Colgate-Palmolive’s Q4 2025 earnings at $0.92 EPS, Q1 2026 earnings at $0.96 EPS, Q3 2026 earnings at $0.96 EPS, Q4 2026 earnings at $0.97 EPS, FY2026 earnings at $3.87 EPS, Q2 2027 earnings at $1.04 EPS, Q3 2027 earnings at $1.03 EPS and FY2027 earnings at $4.12 EPS.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same period in the prior year, the company posted $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 1.9% on a year-over-year basis.

A number of other equities research analysts have also issued reports on CL. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a report on Friday, October 10th. Bank of America cut their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Finally, Raymond James Financial lowered their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.87.

Colgate-Palmolive Trading Up 1.0%

CL opened at $78.86 on Monday. Colgate-Palmolive has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market capitalization of $63.57 billion, a PE ratio of 22.15, a P/E/G ratio of 4.44 and a beta of 0.35. The firm’s fifty day moving average price is $79.08 and its 200 day moving average price is $85.07.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently made changes to their positions in the stock. Westside Investment Management Inc. grew its stake in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares during the last quarter. Saudi Central Bank acquired a new position in shares of Colgate-Palmolive during the first quarter valued at $29,000. Copia Wealth Management bought a new position in shares of Colgate-Palmolive during the third quarter worth about $29,000. Vermillion & White Wealth Management Group LLC grew its position in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the last quarter. Finally, Cloud Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $30,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 17th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s payout ratio is presently 58.26%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.